PubMed:9211933
Annnotations
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 82-91 | Cell | denotes | monocytic | http://purl.obolibrary.org/obo/CL:0000576|http://purl.obolibrary.org/obo/CL:0001054 |
| T3 | 253-262 | Cell | denotes | monocytic | http://purl.obolibrary.org/obo/CL:0000576|http://purl.obolibrary.org/obo/CL:0001054 |
| T5 | 429-438 | Cell | denotes | monocytic | http://purl.obolibrary.org/obo/CL:0000576|http://purl.obolibrary.org/obo/CL:0001054 |
| T7 | 471-480 | Cell | denotes | monocytic | http://purl.obolibrary.org/obo/CL:0000576|http://purl.obolibrary.org/obo/CL:0001054 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-98 | Sentence | denotes | Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. |
| T2 | 99-163 | Sentence | denotes | Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. |
| T3 | 164-271 | Sentence | denotes | Biosynthesis of tumor necrosis factor-alpha (TNF-alpha) is predominantly by cells of the monocytic lineage. |
| T4 | 272-447 | Sentence | denotes | This study examined the role of various cis-acting regulatory elements in the lipopolysaccharide (LPS) induction of the human TNF-alpha promoter in cells of monocytic lineage. |
| T5 | 448-724 | Sentence | denotes | Functional analysis of monocytic THP-1 cells transfected with plasmids containing various lengths of TNF-alpha promoter localized enhancer elements in a region (-182 to -37 base pairs (bp)) that were required for optimal transcription of the TNF-alpha gene in response to LPS. |
| T6 | 725-905 | Sentence | denotes | Two regions were identified: region I (-182 to -162 bp) contained an overlapping Sp1/Egr-1 site, and region II (-119 to -88) contained CRE and NF-kappaB (designated kappaB3) sites. |
| T7 | 906-1025 | Sentence | denotes | In unstimulated THP-1, CRE-binding protein and, to a lesser extent, c-Jun complexes were found to bind to the CRE site. |
| T8 | 1026-1094 | Sentence | denotes | LPS stimulation increased the binding of c-Jun-containing complexes. |
| T9 | 1095-1260 | Sentence | denotes | In addition, LPS stimulation induced the binding of cognate nuclear factors to the Egr-1 and kappaB3 sites, which were identified as Egr-1 and p50/p65, respectively. |
| T10 | 1261-1444 | Sentence | denotes | The CRE and kappaB3 sites in region II together conferred strong LPS responsiveness to a heterologous promoter, whereas individually they failed to provide transcriptional activation. |
| T11 | 1445-1628 | Sentence | denotes | Furthermore, increasing the spacing between the CRE and the kappaB3 sites completely abolished LPS induction, suggesting a cooperative interaction between c-Jun complexes and p50/p65. |
| T12 | 1629-1800 | Sentence | denotes | These studies indicate that maximal LPS induction of the TNF-alpha promoter is mediated by concerted participation of at least two separate cis-acting regulatory elements. |
| T1 | 0-98 | Sentence | denotes | Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. |
| T2 | 99-163 | Sentence | denotes | Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. |
| T3 | 164-271 | Sentence | denotes | Biosynthesis of tumor necrosis factor-alpha (TNF-alpha) is predominantly by cells of the monocytic lineage. |
| T4 | 272-447 | Sentence | denotes | This study examined the role of various cis-acting regulatory elements in the lipopolysaccharide (LPS) induction of the human TNF-alpha promoter in cells of monocytic lineage. |
| T5 | 448-724 | Sentence | denotes | Functional analysis of monocytic THP-1 cells transfected with plasmids containing various lengths of TNF-alpha promoter localized enhancer elements in a region (-182 to -37 base pairs (bp)) that were required for optimal transcription of the TNF-alpha gene in response to LPS. |
| T6 | 725-905 | Sentence | denotes | Two regions were identified: region I (-182 to -162 bp) contained an overlapping Sp1/Egr-1 site, and region II (-119 to -88) contained CRE and NF-kappaB (designated kappaB3) sites. |
| T7 | 906-1025 | Sentence | denotes | In unstimulated THP-1, CRE-binding protein and, to a lesser extent, c-Jun complexes were found to bind to the CRE site. |
| T8 | 1026-1094 | Sentence | denotes | LPS stimulation increased the binding of c-Jun-containing complexes. |
| T9 | 1095-1260 | Sentence | denotes | In addition, LPS stimulation induced the binding of cognate nuclear factors to the Egr-1 and kappaB3 sites, which were identified as Egr-1 and p50/p65, respectively. |
| T10 | 1261-1444 | Sentence | denotes | The CRE and kappaB3 sites in region II together conferred strong LPS responsiveness to a heterologous promoter, whereas individually they failed to provide transcriptional activation. |
| T11 | 1445-1628 | Sentence | denotes | Furthermore, increasing the spacing between the CRE and the kappaB3 sites completely abolished LPS induction, suggesting a cooperative interaction between c-Jun complexes and p50/p65. |
| T12 | 1629-1800 | Sentence | denotes | These studies indicate that maximal LPS induction of the TNF-alpha promoter is mediated by concerted participation of at least two separate cis-acting regulatory elements. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 36-72 | DNA | denotes | tumor necrosis factor-alpha promoter |
| T2 | 76-97 | cell_type | denotes | human monocytic cells |
| T3 | 113-118 | protein | denotes | Egr-1 |
| T4 | 120-125 | protein | denotes | c-Jun |
| T5 | 131-140 | protein | denotes | NF-kappaB |
| T6 | 141-162 | protein | denotes | transcription factors |
| T7 | 180-207 | protein | denotes | tumor necrosis factor-alpha |
| T8 | 209-218 | protein | denotes | TNF-alpha |
| T9 | 253-270 | cell_type | denotes | monocytic lineage |
| T10 | 312-342 | DNA | denotes | cis-acting regulatory elements |
| T11 | 392-416 | DNA | denotes | human TNF-alpha promoter |
| T12 | 429-446 | cell_type | denotes | monocytic lineage |
| T13 | 471-492 | cell_line | denotes | monocytic THP-1 cells |
| T14 | 510-518 | DNA | denotes | plasmids |
| T15 | 549-567 | DNA | denotes | TNF-alpha promoter |
| T16 | 578-595 | DNA | denotes | enhancer elements |
| T17 | 609-631 | DNA | denotes | -182 to -37 base pairs |
| T18 | 690-704 | DNA | denotes | TNF-alpha gene |
| T19 | 754-762 | DNA | denotes | region I |
| T20 | 764-779 | DNA | denotes | -182 to -162 bp |
| T21 | 806-820 | DNA | denotes | Sp1/Egr-1 site |
| T22 | 826-835 | DNA | denotes | region II |
| T23 | 837-848 | DNA | denotes | -119 to -88 |
| T24 | 860-863 | DNA | denotes | CRE |
| T25 | 868-904 | DNA | denotes | NF-kappaB (designated kappaB3) sites |
| T26 | 922-927 | cell_line | denotes | THP-1 |
| T27 | 929-948 | protein | denotes | CRE-binding protein |
| T28 | 974-989 | protein | denotes | c-Jun complexes |
| T29 | 1016-1024 | DNA | denotes | CRE site |
| T30 | 1067-1093 | protein | denotes | c-Jun-containing complexes |
| T31 | 1155-1170 | protein | denotes | nuclear factors |
| T32 | 1178-1201 | DNA | denotes | Egr-1 and kappaB3 sites |
| T33 | 1228-1233 | protein | denotes | Egr-1 |
| T34 | 1238-1245 | protein | denotes | p50/p65 |
| T35 | 1265-1286 | DNA | denotes | CRE and kappaB3 sites |
| T36 | 1290-1299 | DNA | denotes | region II |
| T37 | 1350-1371 | DNA | denotes | heterologous promoter |
| T38 | 1493-1518 | DNA | denotes | CRE and the kappaB3 sites |
| T39 | 1600-1615 | protein | denotes | c-Jun complexes |
| T40 | 1620-1627 | protein | denotes | p50/p65 |
| T41 | 1686-1704 | DNA | denotes | TNF-alpha promoter |
| T42 | 1769-1799 | DNA | denotes | cis-acting regulatory elements |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 32-72 | NP | denotes | the tumor necrosis factor-alpha promoter |
| C2 | 113-118 | NP | denotes | Egr-1 |
| C3 | 180-219 | NP | denotes | tumor necrosis factor-alpha (TNF-alpha) |
| C4 | 240-270 | NP | denotes | cells of the monocytic lineage |
| C6 | 388-416 | NP | denotes | the human TNF-alpha promoter |
| C5 | 350-416 | NP | denotes | lipopolysaccharide (LPS) induction of the human TNF-alpha promoter |
| C7 | 420-446 | NP | denotes | cells of monocytic lineage |
| C8 | 549-567 | NP | denotes | TNF-alpha promoter |
| C9 | 578-607 | NP | denotes | enhancer elements in a region |
| C10 | 638-642 | NP | denotes | that |
| C11 | 686-704 | NP | denotes | the TNF-alpha gene |
| C12 | 725-736 | NP | denotes | Two regions |
| C14 | 860-904 | NP | denotes | CRE and NF-kappaB (designated kappaB3) sites |
| C13 | 754-904 | NP | denotes | region I (-182 to -162 bp) contained an overlapping Sp1/Egr-1 site, and region II (-119 to -88) contained CRE and NF-kappaB (designated kappaB3) sites |
| C15 | 974-989 | NP | denotes | c-Jun complexes |
| C16 | 1026-1041 | NP | denotes | LPS stimulation |
| C17 | 1067-1093 | NP | denotes | c-Jun-containing complexes |
| C18 | 1108-1123 | NP | denotes | LPS stimulation |
| C19 | 1174-1201 | NP | denotes | the Egr-1 and kappaB3 sites |
| C20 | 1203-1208 | NP | denotes | which |
| C21 | 1228-1233 | NP | denotes | Egr-1 |
| C22 | 1238-1245 | NP | denotes | p50/p65 |
| C23 | 1261-1299 | NP | denotes | The CRE and kappaB3 sites in region II |
| C24 | 1394-1398 | NP | denotes | they |
| C25 | 1489-1518 | NP | denotes | the CRE and the kappaB3 sites |
| C26 | 1540-1553 | NP | denotes | LPS induction |
| C27 | 1600-1615 | NP | denotes | c-Jun complexes |
| C28 | 1620-1627 | NP | denotes | p50/p65 |
| C30 | 1682-1704 | NP | denotes | the TNF-alpha promoter |
| C29 | 1657-1704 | NP | denotes | maximal LPS induction of the TNF-alpha promoter |
| R10 | C21 | C2 | coref-ident | Egr-1,Egr-1 |
| R11 | C23 | C14 | coref-ident | The CRE and kappaB3 sites in region II,CRE and NF-kappaB (designated kappaB3) sites |
| R12 | C24 | C23 | coref-pron | they,The CRE and kappaB3 sites in region II |
| R13 | C25 | C23 | coref-ident | the CRE and the kappaB3 sites,The CRE and kappaB3 sites in region II |
| R14 | C26 | C5 | coref-ident | LPS induction,lipopolysaccharide (LPS) induction of the human TNF-alpha promoter |
| R15 | C27 | C17 | coref-ident | c-Jun complexes,c-Jun-containing complexes |
| R1 | C6 | C1 | coref-ident | the human TNF-alpha promoter,the tumor necrosis factor-alpha promoter |
| R2 | C7 | C4 | coref-ident | cells of monocytic lineage,cells of the monocytic lineage |
| R3 | C8 | C6 | coref-ident | TNF-alpha promoter,the human TNF-alpha promoter |
| R4 | C10 | C9 | coref-relat | that,enhancer elements in a region |
| R5 | C11 | C3 | coref-ident | the TNF-alpha gene,tumor necrosis factor-alpha (TNF-alpha) |
| R6 | C13 | C12 | coref-ident | "region I (-182 to -162 bp) contained an overlapping Sp1/Egr-1 site, and region II (-119 to -88) contained CRE and NF-kappaB (designated kappaB3) sites",Two regions |
| R7 | C17 | C15 | coref-ident | c-Jun-containing complexes,c-Jun complexes |
| R8 | C18 | C16 | coref-ident | LPS stimulation,LPS stimulation |
| R9 | C20 | C19 | coref-relat | which,the Egr-1 and kappaB3 sites |
| R16 | C28 | C22 | coref-ident | p50/p65,p50/p65 |
| R17 | C30 | C8 | coref-ident | the TNF-alpha promoter,TNF-alpha promoter |
| R18 | C29 | C26 | coref-ident | maximal LPS induction of the TNF-alpha promoter,LPS induction |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-98 | Sentence | denotes | Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. |
| S2 | 99-163 | Sentence | denotes | Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. |
| S3 | 164-271 | Sentence | denotes | Biosynthesis of tumor necrosis factor-alpha (TNF-alpha) is predominantly by cells of the monocytic lineage. |
| S4 | 272-447 | Sentence | denotes | This study examined the role of various cis-acting regulatory elements in the lipopolysaccharide (LPS) induction of the human TNF-alpha promoter in cells of monocytic lineage. |
| S5 | 448-724 | Sentence | denotes | Functional analysis of monocytic THP-1 cells transfected with plasmids containing various lengths of TNF-alpha promoter localized enhancer elements in a region (-182 to -37 base pairs (bp)) that were required for optimal transcription of the TNF-alpha gene in response to LPS. |
| S6 | 725-905 | Sentence | denotes | Two regions were identified: region I (-182 to -162 bp) contained an overlapping Sp1/Egr-1 site, and region II (-119 to -88) contained CRE and NF-kappaB (designated kappaB3) sites. |
| S7 | 906-1025 | Sentence | denotes | In unstimulated THP-1, CRE-binding protein and, to a lesser extent, c-Jun complexes were found to bind to the CRE site. |
| S8 | 1026-1094 | Sentence | denotes | LPS stimulation increased the binding of c-Jun-containing complexes. |
| S9 | 1095-1260 | Sentence | denotes | In addition, LPS stimulation induced the binding of cognate nuclear factors to the Egr-1 and kappaB3 sites, which were identified as Egr-1 and p50/p65, respectively. |
| S10 | 1261-1444 | Sentence | denotes | The CRE and kappaB3 sites in region II together conferred strong LPS responsiveness to a heterologous promoter, whereas individually they failed to provide transcriptional activation. |
| S11 | 1445-1628 | Sentence | denotes | Furthermore, increasing the spacing between the CRE and the kappaB3 sites completely abolished LPS induction, suggesting a cooperative interaction between c-Jun complexes and p50/p65. |
| S12 | 1629-1800 | Sentence | denotes | These studies indicate that maximal LPS induction of the TNF-alpha promoter is mediated by concerted participation of at least two separate cis-acting regulatory elements. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-18 | lipid | denotes | Lipopolysaccharide |
| T2 | 36-63 | protein_molecule | denotes | tumor necrosis factor-alpha |
| T3 | 76-97 | cell_type | denotes | human monocytic cells |
| T4 | 113-118 | protein_molecule | denotes | Egr-1 |
| T5 | 120-125 | protein_molecule | denotes | c-Jun |
| T6 | 131-140 | protein_complex | denotes | NF-kappaB |
| T7 | 141-162 | protein_family_or_group | denotes | transcription factors |
| T8 | 180-207 | protein_molecule | denotes | tumor necrosis factor-alpha |
| T9 | 209-218 | protein_molecule | denotes | TNF-alpha |
| T10 | 253-270 | cell_type | denotes | monocytic lineage |
| T11 | 312-342 | DNA_family_or_group | denotes | cis-acting regulatory elements |
| T12 | 350-368 | lipid | denotes | lipopolysaccharide |
| T13 | 370-373 | lipid | denotes | LPS |
| T14 | 392-397 | DNA_domain_or_region | denotes | human |
| T15 | 398-407 | protein_molecule | denotes | TNF-alpha |
| T16 | 429-446 | cell_type | denotes | monocytic lineage |
| T17 | 471-480 | cell_line | denotes | monocytic |
| T18 | 481-492 | cell_line | denotes | THP-1 cells |
| T19 | 510-518 | DNA_family_or_group | denotes | plasmids |
| T20 | 549-558 | protein_molecule | denotes | TNF-alpha |
| T21 | 578-595 | DNA_domain_or_region | denotes | enhancer elements |
| T22 | 609-631 | DNA_domain_or_region | denotes | -182 to -37 base pairs |
| T23 | 690-704 | DNA_domain_or_region | denotes | TNF-alpha gene |
| T24 | 720-723 | lipid | denotes | LPS |
| T25 | 754-762 | DNA_domain_or_region | denotes | region I |
| T26 | 764-779 | DNA_domain_or_region | denotes | -182 to -162 bp |
| T27 | 806-810 | DNA_domain_or_region | denotes | Sp1/ |
| T28 | 810-815 | protein_molecule | denotes | Egr-1 |
| T29 | 826-835 | DNA_domain_or_region | denotes | region II |
| T30 | 837-848 | DNA_domain_or_region | denotes | -119 to -88 |
| T31 | 860-863 | DNA_domain_or_region | denotes | CRE |
| T32 | 868-877 | protein_complex | denotes | NF-kappaB |
| T33 | 922-927 | cell_line | denotes | THP-1 |
| T34 | 929-932 | DNA_domain_or_region | denotes | CRE |
| T35 | 974-989 | protein_complex | denotes | c-Jun complexes |
| T36 | 1016-1024 | DNA_domain_or_region | denotes | CRE site |
| T37 | 1026-1029 | lipid | denotes | LPS |
| T38 | 1067-1072 | protein_molecule | denotes | c-Jun |
| T39 | 1108-1111 | lipid | denotes | LPS |
| T40 | 1155-1170 | protein_family_or_group | denotes | nuclear factors |
| T41 | 1228-1233 | protein_molecule | denotes | Egr-1 |
| T42 | 1238-1245 | protein_complex | denotes | p50/p65 |
| T43 | 1290-1299 | DNA_domain_or_region | denotes | region II |
| T44 | 1326-1329 | lipid | denotes | LPS |
| T45 | 1350-1371 | DNA_domain_or_region | denotes | heterologous promoter |
| T46 | 1417-1443 | other_name | denotes | transcriptional activation |
| T47 | 1493-1496 | DNA_domain_or_region | denotes | CRE |
| T48 | 1505-1518 | DNA_domain_or_region | denotes | kappaB3 sites |
| T49 | 1540-1543 | lipid | denotes | LPS |
| T50 | 1600-1605 | protein_molecule | denotes | c-Jun |
| T51 | 1620-1627 | protein_complex | denotes | p50/p65 |
| T52 | 1665-1668 | lipid | denotes | LPS |
| T53 | 1686-1695 | protein_molecule | denotes | TNF-alpha |
| T54 | 1769-1799 | DNA_family_or_group | denotes | cis-acting regulatory elements |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 36-41 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
| T2 | 180-185 | Disease | denotes | tumor | http://purl.obolibrary.org/obo/MONDO_0005070 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 76-81 | OrganismTaxon | denotes | human | 9606 |
| T2 | 392-397 | OrganismTaxon | denotes | human | 9606 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 36-41 | Phenotype | denotes | tumor | HP:0002664 |
| T2 | 180-185 | Phenotype | denotes | tumor | HP:0002664 |